448 related articles for article (PubMed ID: 19234139)
21. Diagnostic performance of quantitative kappa and lambda free light chain assays in clinical practice.
Katzmann JA; Abraham RS; Dispenzieri A; Lust JA; Kyle RA
Clin Chem; 2005 May; 51(5):878-81. PubMed ID: 15774572
[TBL] [Abstract][Full Text] [Related]
22. Monoclonal gammopathy: natural history studied with a retrospective approach.
Steingrimsdottir H; Haraldsdottir V; Olafsson I; Gudnason V; Ogmundsdottir HM
Haematologica; 2007 Aug; 92(8):1131-4. PubMed ID: 17650445
[TBL] [Abstract][Full Text] [Related]
23. Serum free light chains in the diagnosis and monitoring of patients with plasma cell dyscrasias.
Mayo MM; Johns GS
Contrib Nephrol; 2007; 153():44-65. PubMed ID: 17075223
[TBL] [Abstract][Full Text] [Related]
24. [Free light chains assay: Indications and methods].
Martellosio JP; Leleu X; Roblot P; Martin M; Puyade M
Rev Med Interne; 2019 May; 40(5):297-305. PubMed ID: 30862366
[TBL] [Abstract][Full Text] [Related]
25. [Malignant transformation of monoclonal gammopathy of undetermined significance].
Decaux O; Avet-Loiseau H; Grosbois B
Presse Med; 2007 Dec; 36(12 Pt 3):1985-96. PubMed ID: 17509811
[TBL] [Abstract][Full Text] [Related]
26. Monoclonal gammopathy of undetermined significance.
Kyle RA; Rajkumar SV
Clin Lymphoma Myeloma; 2005 Sep; 6(2):102-14. PubMed ID: 16231848
[TBL] [Abstract][Full Text] [Related]
27. [Study of monoclonal gammopathy in Kagawa Prefectural Central Hospital].
Uchida M; Taida N; Kanao M; Kagamihara H; Kuwajima M
Rinsho Byori; 2004 Jul; 52(7):574-9. PubMed ID: 15344556
[TBL] [Abstract][Full Text] [Related]
28. Monoclonal gammopathy-associated pure red cell aplasia.
Korde N; Zhang Y; Loeliger K; Poon A; Simakova O; Zingone A; Costello R; Childs R; Noel P; Silver S; Kwok M; Mo C; Young N; Landgren O; Sloand E; Maric I
Br J Haematol; 2016 Jun; 173(6):876-83. PubMed ID: 26999424
[TBL] [Abstract][Full Text] [Related]
29. Analytical performance and diagnostic potential of immunoassays determining intact immunoglobulin kappa/lambda ratios in monoclonal gammopathies.
Eckold J; Poenisch W; Drogies T; Kratzsch J; Teupser D; Thiery J; Bruegel M
Clin Lab; 2014; 60(9):1491-500. PubMed ID: 25291945
[TBL] [Abstract][Full Text] [Related]
30. The monoclonal gammopathies.
Kyle RA
Clin Chem; 1994 Nov; 40(11 Pt 2):2154-61. PubMed ID: 7955402
[TBL] [Abstract][Full Text] [Related]
31. Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance.
Vachon CM; Kyle RA; Therneau TM; Foreman BJ; Larson DR; Colby CL; Phelps TK; Dispenzieri A; Kumar SK; Katzmann JA; Rajkumar SV
Blood; 2009 Jul; 114(4):785-90. PubMed ID: 19179466
[TBL] [Abstract][Full Text] [Related]
32. Assessment of the analytical performance and the sensitivity of serum free light chains immunoassay in patients with monoclonal gammopathy.
Wolff F; Thiry C; Willems D
Clin Biochem; 2007 Mar; 40(5-6):351-4. PubMed ID: 17239359
[TBL] [Abstract][Full Text] [Related]
33. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
Kyle RA; Rajkumar SV
Curr Hematol Malig Rep; 2010 Apr; 5(2):62-9. PubMed ID: 20425398
[TBL] [Abstract][Full Text] [Related]
34. Serum Free Light Chain Assay in Monoclonal Gammopathic Manifestations.
Lee WS; Singh G
Lab Med; 2019 Oct; 50(4):381-389. PubMed ID: 30957173
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of Serum Free Light Chain in Diagnosis and Monitoring of Plasma Cell Disorders.
Ansari AA; Tipu HN; Ahmed D; Farhan M
Crit Rev Immunol; 2019; 39(3):203-210. PubMed ID: 32421964
[TBL] [Abstract][Full Text] [Related]
36. Timing of acquisition of deletion 13 in plasma cell dyscrasias is dependent on genetic context.
Chiecchio L; Dagrada GP; Ibrahim AH; Dachs Cabanas E; Protheroe RK; Stockley DM; Orchard KH; Cross NC; Harrison CJ; Ross FM;
Haematologica; 2009 Dec; 94(12):1708-13. PubMed ID: 19996118
[TBL] [Abstract][Full Text] [Related]
37. Epidemiological and immunochemical parameters of monoclonal plasma cell dyscrasias of 2121 cases in Algeria.
Belouni R; Allam I; Cherguelaine K; Berkani L; Belaid B; Berkouk Y; Nekkal S; Saidani M; Belhani M; Ghaffor M; Djidjik R
Curr Res Transl Med; 2020 Apr; 68(2):67-70. PubMed ID: 31761679
[TBL] [Abstract][Full Text] [Related]
38. [Monoclonal gammopathies--from MGUS to myeloma].
Hess U; Heijnen IA
Ther Umsch; 2004 Feb; 61(2):161-7. PubMed ID: 15018400
[TBL] [Abstract][Full Text] [Related]
39. [Monoclonal gammopathy--multiple myeloma].
Dietzfelbinger H
MMW Fortschr Med; 2005 Jun; 147(24):32-3, 35-6. PubMed ID: 16001531
[TBL] [Abstract][Full Text] [Related]
40. [Evaluation of the new Hevylite™ IgA assay for the diagnosis and follow-up of monoclonal gammopathies].
Lakomy D; Lemaire-Ewing S; Denimal D; Bastie JN; Lafon I; Caillot D
Ann Biol Clin (Paris); 2013; 71(2):157-63. PubMed ID: 23587579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]